(2)Commission Implementing Regulation (EU) 2021/745note extended the approval period of the active substance flurochloridone until 31 May 2022. That Regulation also extended the approval period of the active substances beflubutamid, benthiavalicarb, boscalid, captan, dimethomorph, ethephon, fluoxastrobin, folpet, formetanate, metazachlor, metribuzin, milbemectin, phenmedipham, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor until 31 July 2022, and of the active substances aluminium ammonium sulphate, aluminium silicate, cymoxanil, extract from tea tree, fat distilation residues, fatty acids C7 to C20, gibberellic acid, gibberellins, hydrolysed proteins, iron sulphate, plant oils/rape seed oil, quartz sand, fish oil, repellents by smell of animal or plant origin/sheep fat, Straight Chain Lepidopteran Pheromones, tebuconazole and urea until 31 August 2022. Commission Implementing Regulation (EU) 2017/195note extended the approval period of the active substance aclonifen until 31 July 2022 and of the active substances 2,5-dichlorobenzoic acid methylester, acetic acid, aluminium phosphide, calcium carbide, dodemorph, ethylene, magnesium phosphide, metamitron, plant oils/clove oil, plant oils/spear mint oil, pyrethrins and sulcotrione until 31 August 2022. Commission Implementing Regulation (EU) 2017/2069note extended the approval period of the active substance proquinazid until 31 July 2022.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.